✦ LIBER ✦

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

✍ Scribed by Bartlett, Nancy L; Chen, Robert; Fanale, Michelle A; Brice, Pauline; Gopal, Ajay; Smith, Scott E; Advani, Ranjana; Matous, Jeffrey V; Ramchandren, Radhakrishnan; Rosenblatt, Joseph D; Huebner, Dirk; Levine, Pamela; Grove, Laurie; Forero-Torres, Andres

Book ID: 125403604
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 336 KB
Volume: 7
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-7-24

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brentuximab vedotin does not cause clini

Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies

✍ T. H. Han, R. Chen, R. Advani, R. B. Berryman… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 312 KB

A Phase I Weekly Dosing Study of Brentux

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

✍ Fanale, M. A.; Forero-Torres, A.; Rosenblatt, J. D.; Advani, R. H.; Franklin, A. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 267 KB

P959: Clinical and neurophysiological sp

P959: Clinical and neurophysiological spectrum of peripheral neurotoxicity in patients with CD30-positive malignancies, treated with Brentuximab Vedotin

✍ Pastorelli, F.; Plasmati, R.; Salvi, F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Handbook of Therapeutic Antibodies (Dübe

Handbook of Therapeutic Antibodies (Dübel/Handbook of Therapeutic Antibodies) || Brentuximab Vedotin (Adcetris®) for the Treatment of CD30-Positive Hematologic Malignancies

✍ Dübel, Stefan; Reichert, Janice M. 📂 Article 📅 2014 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 314 KB

Extended retreatment with brentuximab ve

Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma

✍ Foyil, Kelley V.; Kennedy, Dana A.; Grove, Laurie E.; Bartlett, Nancy L.; Cashen 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 229 KB

Brentuximab vedotin in patients aged 60

Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy

✍ Gopal, Ajay K.; Bartlett, Nancy L.; Forero-Torres, Andres; Younes, Anas; Chen, R 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 156 KB